Resources

QQFS Overview
QQFS Overview

With headquarters based in Sweden, we are in a geographically advantageous position to provide services in some of Europe’s most challenging markets including the Nordics, Benelux, Austria and Switzerland.

Instant Insights
Instant Insight

The M3 Global Research Instant Insight offering is designed to provide quick responses to the most important questions. Read more now to learn how Instant Insight will help when you need to know the answer fast.

QQFS Capabilities
QQFS Capabilities

QQFS, a Gothenburg based fieldwork agency and now a wholly owned subsidiary of the M3 Group, is a leader in providing data-collection services for the pharmaceutical and healthcare industry. In 2017 we delivered over 21,000 completes across 1,003 projects in our core markets.

QQFS Studio
QQFS Studio

QQFS provides two spacious and comfortable viewing facilities set within our premises in Gothenburg, Sweden. It is ideal for focus groups and face-to-face interviews. We offer the viewing facilities on a ‘hire only‘ basis or in combination with our fieldwork services.

United Kingdom Country Profile
United Kingdom

The United Kingdom (UK) is a sovereign state located off the north-western coast of Europe, made up of four nations: England, Wales, Scotland, and Northern Ireland. Healthcare in the UK is handled at a subnational level with England, Northern Ireland, Scotland, and Wales each having their own systems of publicly-funded healthcare. Learn more by reading our United Kingdom Country Profile.

France Profile
France

The population of France has experienced marginal year-over-year growth for decades, while wealth has risen, leading to a highly developed country with a stable population model. Learn about France's healthcare in this country profile.

Japan Profile
Japan

Over the last twenty years, Japan’s healthcare spending has been on the rise and this trend is expected to continue. A fast-growing, aging population and increasing cases of chronic diseases make Japan a long-term growth market for pharmaceutical companies. Between 2014 and 2018, healthcare spending is expected to rise by an average of three percent a year, reaching around 10 percent of GDP by the end of 2018.


We are proud members and supporters of